Trial Profile
Fosamprenavir + ritonavir vs lopinavir/ritonavir in treatment-naive HIV-1-infected men.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Fosamprenavir (Primary) ; Ritonavir (Primary) ; Lopinavir/ritonavir
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 05 Nov 2010 New trial record.
- 18 Oct 2010 Results have been published in Antiviral Therapy.